18
Views
30
CrossRef citations to date
0
Altmetric
Gene Expression

Multiple Properties of the Splicing Repressor SRp38 Distinguish It from Typical SR Proteins

, &
Pages 8334-8343 | Received 10 Feb 2005, Accepted 23 Jun 2005, Published online: 27 Mar 2023

REFERENCES

  • Billings, P. B., R. W. Allen, F. C. Jensen, and S. O. Hoch. 1982. Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity. J. Immunol. 128:1176–1180.
  • Blencowe, B. J. 2000. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25:106–110.
  • Bond, U. 1988. Heat shock but not other stress inducers leads to the disruption of a sub-set of snRNPs and inhibition of in vitro splicing in HeLa cells. EMBO J. 7:3509–3518.
  • Burge, C. B., T. Tuschl, and P. A. Sharp. 1999. Splicing of precursors to mRNAs by the spliceosomes, p. 525–560. In R. F. Gesteland, T. R. Cech, and J. F. Atkins (ed.), The RNA world, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  • Caceres, J. F., and A. R. Krainer. 1993. Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains. EMBO J. 12:4715–4726.
  • Chen, T., F. M. Boisvert, D. P. Bazett-Jones, and S. Richard. 1999. A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines. Mol. Cell. Biol. 10:3015–3033.
  • Colwill, K., L. L. Feng, J. M. Yeakley, G. D. Gish, J. F. Caceres, T. Pawson, and X. D. Fu. 1996. SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors. J. Biol. Chem. 271:24569–24575.
  • Cramer, P., J. F. Caceres, D. Cazalla, S. Kadener, A. F. Muro, F. E. Baralle, and A. R. Kornblihtt. 1999. Coupling of transcription with alternative splicing: RNA Pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol. Cell 4:251–258.
  • Denegri, M., I. Chiodi, M. Corioni, F. Cobianchi, S. Riva, and G. Biamonti. 2001. Stress-induced nuclear bodies are sites of accumulation of pre-mRNA processing factors. Mol. Cell. Biol. 12:3502–3514.
  • Gall, J. G. 2003. The centennial of the Cajal body. Nat. Rev. Mol. Cell Biol. 4:975–980.
  • Gall, J. G., M. Bellini, Z. Wu, and C. Murphy. 1999. Assembly of the nuclear transcription and processing machinery: Cajal bodies (coiled bodies) and transcriptosomes. Mol. Biol. Cell 10:4385–4402.
  • Gaston, K., and P. S. Jayaraman. 2003. Transcriptional repression in eukaryotes: repressors and repression mechanisms. Cell. Mol. Life Sci. 60:721–741.
  • Ghetti, A., S. Pinol-Roma, W. M. Michael, C. Morandi, and G. Dreyfuss. 1992. hnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNPs. Nucleic Acids Res. 20:3671–3678.
  • Graveley, B. R. 2000. Sorting out the complexity of SR protein functions. RNA 6:1197–1211.
  • Graveley, B. R., K. J. Hertel, and T. Maniatis. 1998. A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. EMBO J. 17:6747–6756.
  • Hirose, Y., R. Tacke, and J. L. Manley. 1999. Phosphorylated RNA polymerase II stimulates pre-mRNA splicing. Genes Dev. 13:1234–1239.
  • Huang, S. 2000. Review: perinucleolar structures. J. Struct. Biol. 129:233–240.
  • Huang, Y., R. Gattoni, J. Stevenin, and J. A. Steitz. 2003. SR splicing factors serve as adapter proteins for TAP-dependent mRNA export. Mol. Cell 11:837–843.
  • Johnson, J. M., J. Castle, P. Garrett-Engele, Z. Kan, P. M. Loerch, C. D. Armour, R. Santos, E. E. Schadt, R. Stoughton, and D. D. Shoemaker. 2003. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141–2144.
  • Jurica, M. S., and M. J. Moore. 2003. Pre-mRNA splicing: awash in a sea of proteins. Mol. Cell 12:5–14.
  • Kan, Z., E. C. Rouchka, W. R. Gish, and D. J. States. 2001. Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. Genome Res. 11:889–900.
  • Kedersha, N., and P. Anderson. 2002. Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochem. Soc. Trans. 30:963–969.
  • Kedersha, N. L., M. Gupta, W. Li, I. Miller, and P. Anderson. 1999. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J. Cell Biol. 147:1431–1442.
  • Kielkopf, C. L., S. Lucke, and M. R. Green. 2004. U2AF homology motif: protein recognition in the RRM world. Genes Dev. 18:1513–1526.
  • Kohtz, J. D., S. F. Jamison, C. L. Will, P. Zuo, R. Luhrmann, M. A. Garcia-Blanco, and J. L. Manley. 1994. Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature 368:119–124.
  • Komatsu, M., E. Kominami, K. Arahata, and T. Tsukahara. 1999. Cloning and characterization of two neural-salient serine/arginine-rich (NSSR) proteins involved in the regulation of alternative splicing in neurones. Genes Cells 4:593–606.
  • Lamond, A. I., and J. E. Sleeman. 2003. Nuclear substructure and dynamics. Curr. Biol. 13:R825–R828.
  • Lamond, A. I., and D. L. Spector. 2003. Nuclear speckles: a model for nuclear organelles. Nat. Rev. Mol. Cell Biol. 4:605–612.
  • Lejeune, F., X. Li, and L. E. Maquat. 2003. Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities. Mol. Cell 12:675–687.
  • Lemaire, R., J. Prasad, T. Kashima, J. Gustafson, J. L. Manley, and R. Lafyatis. 2002. Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins. Genes Dev. 16:594–607.
  • Li, J., D. C. Barnard, and J. G. Patton. 2002. A unique glutamic acid-lysine (EK) domain acts as a splicing inhibitor. J. Biol. Chem. 277:39485–39492.
  • Liu, K. J., and R. M. Harland. 2005. Inhibition of neurogenesis by SRp38, a neuroD-regulated RNA-binding protein. Development 132:1511–1523.
  • Manley, J. L., and R. Tacke. 1996. SR proteins and splicing control. Genes Dev. 10:1569–1579.
  • Mironov, A. A., J. W. Fickett, and M. S. Gelfand. 1999. Frequent alternative splicing of human genes. Genome Res. 9:1288–1293.
  • Misteli, T., and D. L. Spector. 1999. RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo. Mol. Cell 3:697–705.
  • Modrek, B., A. Resch, C. Grasso, and C. Lee. 2001. Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res. 29:2850–2859.
  • Prasanth, K. V., P. A. Sacco-Bubulya, S. G. Prasanth, and D. L. Spector. 2003. Sequential entry of components of the gene expression machinery into daughter nuclei. Mol. Biol. Cell 14:1043–1057.
  • Sanford, J. R., N. K. Gray, K. Beckmann, and J. F. Caceres. 2004. A novel role for shuttling SR proteins in mRNA translation. Genes Dev. 18:755–768.
  • Shen, H., J. L. Kan, and M. R. Green. 2004. Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly. Mol. Cell 13:367–376.
  • Sheth, U., and R. Parker. 2003. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300:805–808.
  • Shin, C., Y. Feng, and J. L. Manley. 2004. Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. Nature 427:553–558.
  • Shin, C., and J. L. Manley. 2002. The SR protein SRp38 represses splicing in M phase cells. Cell 111:407–417.
  • Shin, C., and J. L. Manley. 2004. Cell signalling and the control of pre-mRNA splicing. Nat. Rev. Mol. Cell Biol. 5:727–738.
  • Smith, C. W., and J. Valcarcel. 2000. Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci. 25:381–388.
  • Spector, D. L., X. D. Fu, and T. Maniatis. 1991. Associations between distinct pre-mRNA splicing components and the cell nucleus. EMBO J. 10:3467–3481.
  • Spector, D. L., G. Lark, and S. Hunag. 1992. Differences in snRNP localization between transformed and nontransformed cells. Mol. Biol. Cell 3:555–569.
  • Tacke, R., and J. L. Manley. 1995. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14:3540–3551.
  • Tacke, R., and J. L. Manley. 1999. Determinants of SR protein specificity. Curr. Opin. Cell Biol. 11:358–362.
  • Wang, J., S. H. Xiao, and J. L. Manley. 1998. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing. Genes Dev. 12:2222–2233.
  • Wu, J. Y., and T. Maniatis. 1993. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 75:1061–1070.
  • Xiao, S. H., and J. L. Manley. 1997. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev. 11:334–344.
  • Xiao, S. H., and J. L. Manley. 1998. Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2. EMBO J. 17:6359–6367.
  • Yang, L., L. J. Embree, and D. D. Hickstein. 2000. TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol. Cell. Biol. 20:3345–3354.
  • Zhang, Z., and A. R. Krainer. 2004. Involvement of SR proteins in mRNA surveillance. Mol. Cell 16:597–607.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.